Policy & Medicine August 20, 2024
A recent study published in PLOS ONE titled “Assessing the Impact of the Physician Payments Sunshine Act on Pharmaceutical Companies’ Payments to Physicians,” explores the complex relationship between industry payments to physicians and their prescribing practices. The study analyzed data from the years 2012 to 2019, with a focus on two payment categories: meals and travel. The study provides a nuanced view of how financial interactions with pharmaceutical companies can influence the early adoption of new medications, which, in many cases, may benefit patient care.
Methods of Research
The researchers analyzed data from the ProPublica Dollars for Docs (PDFD) database for the years of 2012 and 2013 and the Open Payments database for years 2014 through 2019. The PDFD...
Today's Sponsors
Today's Sponsor